VIDEO: Amgen to Expand in RI With "Next-Generation" Biomanufacturing Plant

GoLocalProv Business Team

VIDEO: Amgen to Expand in RI With "Next-Generation" Biomanufacturing Plant

Amgen
Leading biotechnology company, Amgen, announced that it will expand in Rhode Island with a new $160 million "next-generation" biomanufacturing plant.

The plant will be the first of its kind in the United States.

SEE VIDEO INTERVIEW WITH GOVERNOR GINA RAIMONDO BELOW

GET THE LATEST BREAKING NEWS HERE -- SIGN UP FOR GOLOCAL FREE DAILY EBLAST

"I am thrilled that Amgen is planning to expand and bring new, highly skilled jobs to Rhode Island and further enhance the State's life sciences community and manufacturing expertise. We welcome Amgen's future healthcare advancements for patients around the world that will come from this new biomanufacturing plant,” said Governor Gina Raimondo.

The New Plant

Amgen's new biomanufacturing plant will be built on the current Amgen Rhode Island 75-acre campus in West Greenwich and is expected to create approximately 150 additional manufacturing positions with the potential for up to 300 in the coming years.

In addition, the project will create hundreds of construction and validation jobs.

The new plant will employ Amgen's next-generation biomanufacturing capabilities and manufacture products for the U.S. and global markets.

Amgen currently employs 625 full-time employees in Rhode Island.

"We are excited that Amgen Rhode Island was chosen as the location to build the new biomanufacturing plant. It is a testament to our skilled, dedicated workforce and Amgen's continued presence in Rhode Island, which will enable ongoing collaborations with local academic institutions and the broader Rhode Island community,”  said Tia Bush, vice president of Operations at Amgen Rhode Island.

RI Supports Project

The Board of the Rhode Island Commerce Corporation approved tax credits through the Rebuild Rhode Island tax credit program and the Qualified Jobs Incentive Act. The value of the Rebuild Rhode Island Tax Credit is $2.2 million.

There is potential for Amgen to receive an additional $1.25 million upon meeting established performance metrics.

The estimated value of the Qualified Jobs tax credits is $600,000 per year over 10 years. The credits are only paid out after the jobs are created and employees have paid income tax for a full year.


17 Biggest Business Stories of 2017

Enjoy this post? Share it with others.